Hagan Introduces Long-Anticipated TREAT Act, Sans Progressive, Exceptional Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Bill looks to expand accelerated approval rather than create new approval pathways, and also would reform conflict of interest rules for FDA advisory committees.